C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 405/06 (2006.01) A61K 31/4184 (2006.01) A61K 31/5383 (2006.01) A61P 3/10 (2006.01) A61P 5/40 (2006.01) A61P 13/12 (2006.01) C07D 405/14 (2006.01) C07D 498/04 (2006.01)
Patent
CA 2751901
The present invention provides a compound of the formula: Compound (I) or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising Compound (I) in combination with a suitable carrier, diluent, or excipient; and methods for treating physiological disorders, particularly congestive heart failure, hypertension, diabetic nephropathy, or chronic kidney disease, comprising administering Compound (I), or a pharmaceutically acceptable salt thereof.
La présente invention porte sur un composé de la formule (I) ou sur un sel pharmaceutiquement acceptable de celui-ci; sur des compositions pharmaceutiques comprenant le composé (I) en combinaison avec un support, diluant ou excipient approprié; et sur des procédés de traitement de troubles physiologiques, en particulier d'insuffisance cardiaque congestive, d'hypertension, de néphropathie diabétique ou de maladie rénale chronique, comprenant l'administration du composé (I) ou d'un sel pharmaceutiquement acceptable de celui-ci.
Coates David Andrew
Gavardinas Konstantinos
Jadhav Prabhakar Kondaji
Eli Lilly And Company
Gowling Lafleur Henderson Llp
LandOfFree
Mineralocorticoid receptor antagonist and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mineralocorticoid receptor antagonist and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mineralocorticoid receptor antagonist and methods of use will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1751556